Heru, the leader in AI-powered vision diagnostics, today announced the U.S. launch of the new PretestPro on its Heru Prime wearable platform. PretestPro runs four pretest exams in just 90 seconds. In keeping with Heru’s evergreen commitment to customers, all future and current Heru Prime customers will receive PretestPro free of charge through an automatic software update.

“PrestestPro isn’t just a faster test. It is a fundamentally different way to structure the diagnostic workflow,” said Mohamed Abou Shousha, M.D., Ph.D., founder and CEO of Heru and professor of clinical ophthalmology at the Bascom Palmer Eye Institute, University of Miami Miller School of Medicine. “Traditional pretesting requires multiple devices and several manual steps. PretestPro consolidates these tests into a single wearable exam that runs about three times faster than traditional testing.”

“The new PretestPro is great. It saves us precious time working up our pretests, and our patients love it,” said Kelly Kiersch, PC Optometrist Assistant, Focus on Eyes, a Member of Vision Source.

Built on 15 years of vision science research and clinical validation work originating at Bascom Palmer, the #1 ranked eye hospital in the nation, PretestPro leverages virtual reality (VR) and eye tracking to capture multiple tests in a single, guided workflow that produces a consolidated, quantitative report of the results to replace subjective, manual testing.

Patients are guided to maintain fixation by Nora, Heru’s patient-friendly fixation target, while PretestPro runs four critical pretesting eye exams, including 8-point suprathreshold, near cover test, extraocular motility (EOM), and quantitative pupillometry including RAPD and PERRLA status. Heru has published peer‑reviewed evidence across the VR and eye‑tracking modalities powering PretestPro, reflecting their commitment to transparency and high clinical performance. Heru Prime users can also run Heru’s Visual Acuity Testing for an additional 30 seconds, meaning clinicians can now complete 50% of their pretesting in just 2 minutes, allowing more time for exam lane throughput and patient education.

Replacing manual workflows and a roomful of legacy equipment, Heru’s portable platform digitizes and automates manual eye tests for efficiency and clinical consistency, and can be worn in any pre-test area, in the waiting room, or even in remote locations. Nora, an AI-driven fixation target guides the patient through various modalities, which could include the new PretestPro; suprathreshold VF; full threshold VF 24-2, 10-2, and 30-2; Esterman VF; visual acuity testing; Ishihara color vision test; near and distance cover tests; quantitative pupillometry; and extraocular motility (EOM) assessment.

About Heru. Heru is a clinical diagnostic software company that helps clinics deliver more consistent workflows, clearer results, and better patient and technician experiences without compromising clinical rigor. Born out of the University of Miami’s Bascom Palmer Eye Institute, the #1 eye hospital in the U.S., Heru digitizes and automates multiple eye exams in a single, portable, FDA-registered wearable device. The platform is backed by 70+ patents, has tested 1.9M+ eyes, and is extensively clinically validated to replace several legacy diagnostic devices, increasing practice efficiency and improving the standard of care. Heru is committed to democratizing vision care by making advanced diagnostic technology accessible anytime, anywhere. For more information, visit seeheru.com.

About Bascom Palmer Eye Institute. Bascom Palmer Eye Institute of the University of Miami Health System, is ranked the #1 eye hospital in the United States by U.S. News & World Report. Bascom Palmer serves as the Department of Ophthalmology for the University of Miami Miller School of Medicine. Its physicians and scientists are recognized as international leaders in their fields, dedicated to advancing vision research and providing state-of-the-art patient care.

Sources:

  1. Johnson C, Sayed A, McSoley J, et al. Comparison of visual field test measurements with a novel approach on a wearable headset to standard automated perimetry. J Glaucoma 2023;32:647-657.

  2. Vera J, Glazier AN, Dunbar, MT, et al. Evaluating the clinical validity of commercially available virtual reality headsets for visual field testing: A systematic review. Vision 2025;9(4):8.

PretestPro and company logo are trademarks of Heru.

Media gallery

About The Author
Business Wire